Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Wylie

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancerVijay K Sangar, Catherine A McBain, Jeanette Lyons, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 28, 2008
Report on the early efficacy and tolerability of I(125) permanent prostate brachytherapy from a UK multi-institutional databaseD M Mitchell, P Mandall, D Bottomley, et al.
Angewandte Chemie (International Ed. in English)|May 6, 2020
Axial Elongation of Mononuclear Lanthanide Metallocenophanes: Magnetic Properties of Dysprosium- and Terbium-[1]Ruthenocenophane ComplexesGabrielle M Risica, Veacheslav Vieru, Branford O Wilkins, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2009
Efficacy of data capture for patient-reported toxicity following radiotherapy for prostate or cervical cancerDamian J J Farnell, Jacqueline Routledge, Rita Hannon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 22, 2010
Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapyDamian J J Farnell, Paula Mandall, Carmel Anandadas, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapyRichard A Cowan, Catherine A McBain, W David J Ryder, et al.
Familial Cancer|June 27, 2019
Multiple primary malignancies associated with a germline SMARCB1 pathogenic variantJudith A Eelloo, Miriam J Smith, Naomi L Bowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancerAnanya Choudhury, Ric Swindell, John P Logue, et al.
BJU International|November 19, 2010
Early prostate cancer--which treatment do men prefer and why?Carmel N Anandadas, Noel W Clarke, Susan E Davidson, et al.
Lancet (London, England)|May 19, 2024
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trialChris C Parker, Noel W Clarke, Adrian D Cook, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancerVijay K Sangar, Catherine A McBain, Jeanette Lyons, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 28, 2008
Report on the early efficacy and tolerability of I(125) permanent prostate brachytherapy from a UK multi-institutional databaseD M Mitchell, P Mandall, D Bottomley, et al.
Angewandte Chemie (International Ed. in English)|May 6, 2020
Axial Elongation of Mononuclear Lanthanide Metallocenophanes: Magnetic Properties of Dysprosium- and Terbium-[1]Ruthenocenophane ComplexesGabrielle M Risica, Veacheslav Vieru, Branford O Wilkins, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2009
Efficacy of data capture for patient-reported toxicity following radiotherapy for prostate or cervical cancerDamian J J Farnell, Jacqueline Routledge, Rita Hannon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 22, 2010
Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapyDamian J J Farnell, Paula Mandall, Carmel Anandadas, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapyRichard A Cowan, Catherine A McBain, W David J Ryder, et al.
Familial Cancer|June 27, 2019
Multiple primary malignancies associated with a germline SMARCB1 pathogenic variantJudith A Eelloo, Miriam J Smith, Naomi L Bowers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancerAnanya Choudhury, Ric Swindell, John P Logue, et al.
BJU International|November 19, 2010
Early prostate cancer--which treatment do men prefer and why?Carmel N Anandadas, Noel W Clarke, Susan E Davidson, et al.
Lancet (London, England)|May 19, 2024
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trialChris C Parker, Noel W Clarke, Adrian D Cook, et al.
Pageof 10